Please assess the completion status of the following clinical trial:

Trial Title: Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Premature infants (\<37 weeks gestation)~* More than 1 significant Apnea q 8h (\> 20 sec or \< 20 sec with bradycardia or desaturation)~* Already treated with caffeine~Exclusion Criteria:~* Intubation~* congenital malformation~* symptomatic apnea

- Gender: ALL
- Minimum Age: 1 Week
- Maximum Age: 3 Months
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Treatment based on patient weight;
- 2 (Type: ACTIVE_COMPARATOR): Treatment based on a chart taking into account weight, age and gender

Based on this trial design, predict the completion outcome and termination type (if applicable).